Inspire Medical Systems (NYSE:INSP – Get Free Report) and Enovis (NYSE:ENOV – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.
Institutional & Insider Ownership
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 98.5% of Enovis shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Comparatively, 2.9% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Inspire Medical Systems and Enovis”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Inspire Medical Systems | $915.25 million | 1.31 | $145.42 million | $4.49 | 9.23 |
| Enovis | $2.25 billion | 0.58 | -$1.18 billion | ($19.88) | -1.14 |
Inspire Medical Systems has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Inspire Medical Systems and Enovis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Inspire Medical Systems | 14.33% | 10.35% | 8.81% |
| Enovis | -49.92% | 10.32% | 4.57% |
Risk & Volatility
Inspire Medical Systems has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Enovis has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Inspire Medical Systems and Enovis, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Inspire Medical Systems | 3 | 13 | 4 | 0 | 2.05 |
| Enovis | 1 | 0 | 7 | 1 | 2.89 |
Inspire Medical Systems currently has a consensus price target of $81.84, indicating a potential upside of 97.40%. Enovis has a consensus price target of $44.50, indicating a potential upside of 96.60%. Given Inspire Medical Systems’ higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Enovis.
Summary
Inspire Medical Systems beats Enovis on 8 of the 15 factors compared between the two stocks.
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
About Enovis
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
